Abstract
Neuronal maintenance, function and repair capabilities may depend in vivo — as they do in vitro — on the availability to the neuron of appropriate extrinsic agents. In vivo, nerve cells are subject to influences, both stimulatory and inhibitory, derived from their physical environment (extracellular fluid and matrix) and their cellular environment (glial cells, presynaptic neurons, postsynaptic innervation targets), which can apply in pathological as well as in normal circumstances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Yamakawa T, Nagai Y (1978) Glycolipids at the cell surface and their biological functions. Trends Biochem Sci 3: 12 8–131
Ando S (1983) Gangliosides in the nervous system. Neurochem Int 5: 50 7–537
Suzuki K (1965) The pattern of mammalian brain gangliosides. III. Regional and developmental differences. J Neurochem 12: 969–979
Rapport I, Gorio A (1981) Gangliosides in Neurological and Neuromuscular Function, Developmental and Repair. Raven, New York.
Purpura DP, Baker HJ (1977) Neurite induction in mature cortical neurones in feline GMl-ganglioside storage disease. Nature (Lond) 266: 553–554
Purpura DP, Baker HJ (1978) Meganeurites and other aberrant processes of neurons in feline GMl-gangliosidosis: a Golgi study. Brain Res 143: 13–26
Weiss P, Hiscoe HB (1948) Experiments on the mechanism of nerve growth. J Exp Zool 107: 315–396
Levi-Montalcini R, Meyer R, Hamburger V (1954) In vitro experiments on the effect of mouse sarcoma 180 and 37 on the spinal and sympathetic ganglia of the chick embryo. Cancer Res 14: 4 9–57
Roisen FJ, Bartfield H, Nagele R, Yorke E (1981) Ganglios ide stimulation of axonal sprouting in vitro. Science 214: 577–578
Leon A, Benvegnu D, Dal Toso R, Presti D, Facci L, Giorgi O, Toffano G (1984) Dorsal root ganglia and nerve growth factor: a model for understanding the mechanism of GMl effects on neuronal repair. J Neurosci Res 12: 277–287
Skaper SD, Selak I, Varon S (1983) Serum - and substratum - dependent modulation of neuritic growth. J Neurosci Res 9: 359–369
Skaper SD, Varon S (1985) Ganglioside GMl overcomes serum inhibition of neuritic outgrowth. Int J Devi Neurosci 3: 187–198
Barbin G, Manthorpe M, Varon S (1984) Purification of the chick eye Ciliary Neuronotrophic Factor ( CNTF ). J Neurochem 43: 1468–1478
Skaper SD, Katoh-Semba R, Varon S (1985) GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions. Dev Brain Res 23: 19–26
Selak I, Skaper SD, Varon S (1985) Pyruvate participation in the low molecular weight trophic activity for CNS neurons in glia-conditioned media. J Neurosci 5: 23–28
Doherty Pf Dickson JG, Flanigan TP, Walsh FS (1985) Ganglioside GM1 does not initiate, but enhances neurite regeneration of nerve growth factor-dependent sensory neurones. J Neurochem 44: 1259–1265
Ferrari G, Fabris M, Gorio A (1983) Gangliosides enhance neurite outgrowth in PC12 cells. Dev Brain Res 8: 215–222
Katoh-Semba R, Skaper SD, Varon S (1984) Interaction of GM1 ganglioside with PC 12 pheochromocytoma cells: serum and NGF-dependent effects on neuritic growth (and proliferation). J Neurosci Res 12: 299–310
Toffano G, Benvegnù D, Bonetti AC, Facci L, Leon A, Orlando R, Ghidoni R, Tettamanti G (1980) Interactions of GM1 ganglioside with crude rat brain neuronal membranes. J Neurochem 35: 861–866
Leon A, Facci L, Benvegnù D, Toffano G (1982) Morphological and biochemical effects of gangliosides in neuroblastoma cells. Dev Neurosci 5: 108–114
Facci L, Leon A, Toffano G, Sonnino S, Ghidoni R, Tettamanti G (1984) Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J Neurochem 42: 299–305
Appel SH (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer’s disease. Ann Neurol 10: 499–505
Varon S, Manthorpe M, Williams LR (1984) Neuronotrophic and neurite promoting factors and their clinical potentials. Dev Neurosci 6: 73–100
Björkland A, Stenevi U (1981) In vivo evidence for a hippocampal adrenergic neurotrophic factor specifically released on septal deafferentiation. Brain Res 229: 403–428
Manthorpe M, Nieto-Sampedro M, Skaper SD, Lewis ER, Barbin G, Longo FM, Cotman CW, Varon S (1983) Neuronotr ophic activity in brain wounds of the developing rat. Correlation with implant survival in the wound cavity. Brain Res 267: 47–56
Nieto-Sampedro M, Manthorpe M, Barbin G, Varon S, Cotman CW (1983) Injury-induced neuronotrophic activity in adult rat brain. Correlation with survival of delayed implants in a wound cavity. J Neurosci 3: 2219–2229
Gage FH, Björkland A, Stenevi U (1984) Denervation releases a neuronal survival factor in adult rat hippocampus. Nature (London) 308: 637–639
Korsching S, Heumann R, Thoenen H, Hefti F (1986) Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor ( NGF) without change in mRNANGF content. Neurosci Lett 66: 175–180
Yoshida K, Kohsaka S, Idei T, Nii S, Otani M, Toya S, Tsukada Y (1986) Septal deafferentiation enhances the neurotrophic effects of rat hippocampus on cultured neural cells from the central nervous system. Neurosci Lett 66: 181–186
Longo FM, Skaper SD, Manthorpe M, Williams LR, Lundborg G, Varon S (1983) Temporal changes in neuronotrophic activities accumulating in vivo within nerve regeneration chambers. Exp Neurol 81: 756–769
Schonfeld AR, Heacock AM, Katzman R (1985) Neuronotrophic factors: Effects on central cholinergic regeneration in vivo. Brain Res 336: 297–301
Nieto-Sampedro M, Whittemore SR, Needels DL, Larson J, Cotman CW (1984) The survival of brain transplants is enhanced by extracts from injured brain. Proc Natl Acad Sci USA 81: 62 50–6254
Korsching S, Auburger G, Heumann R, Scott J, Thoenen H (1985) Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 4: 1389–1393
Sheldon DL, Reichardt LF (1986) Studies on the expression of the nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggests that NGF functions as a trophic factor for several distinct populations of neurons. Proc Natl Acad Sci USA 83: 2714–2718
Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6: 2155–2162
Gorio A, Carmignoto G, Facci L, Finesso M (1980) Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth. Brain Res 197: 236–241
Sparrow JR, Grafstein B (1982) Sciatic nerve regeneration in ganglioside-treated rats. Exp Neurol 77: 230–235
Robb GR, Keynes RJ (1984) Stimulation of nodal and terminal sprouting of mouse motor nerves by gangliosides. Brain Res 295: 368–371
Agnati LF, Fuxe K, Calzà L, Benfenati F, Cavicchioli L, Toffano G, Goldstein M (1983) Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol Scand 119: 347–363
Toffano G, Savoini GE, Moroni F, Lombardi G, Calzà L, Agnati LF (1984) Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat. Brain Res 296: 233–239
Wojcik M, Ulas J, Oderfeld-Nowak B (1982) The stimulating effect of ganglioside injections on the recovery of choline acetyl transferase and acetylcholinesterase activities in the hippocampus of the rat after septallesions. Neurosci 7: 495–499
Gradkowska M, Skup M, Kiedrowski L, Calzolari S, Oderfeld-Nowak B (1986) The effect of GM1 ganglioside on cholinergic and serotonergic systems in the rat hippocampus following partial denervation is dependent on the degree of fiber degeneration. Brain Res 375: 417–422
Ceccarelli B, Aporti F, Finesso M (1976) Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation. Adv Exp Med Biol 71: 275–293
Karpiak SE (1983) Ganglioside treatment improves recovery of alteration behavior after unilateral entorhinal cortex lesion. Exp Neurol 81: 330–339
Sabel BA, Slavin MD, Stein DG (1984) GM1 ganglioside treatment facilitates behavioral recovery following bilateral brain damage. Science 225: 340–342
Li YS, Mahadik SP, Rapport MM, Karpiak SE (1986) Acute effects of GM1 ganglioside: reduction in both behavioral asymmetry and loss of Na+, K+-ATPase after nigrostriatal transection. Brain Res 377: 292–297
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Skaper, S.D. (1987). Modulation of Neuronotrophic Factor Action by Exogenous Gangliosides. In: Rahmann, H. (eds) Gangliosides and Modulation of Neuronal Functions. NATO ASI Series, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71932-5_44
Download citation
DOI: https://doi.org/10.1007/978-3-642-71932-5_44
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71934-9
Online ISBN: 978-3-642-71932-5
eBook Packages: Springer Book Archive